Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Abbott and Deltanoid to develop fourth generation active D therapies

July 27, 2004

FDA extends Fosrenol review

July 22, 2004

Significant association found between coronary artery risk factors and erectile dysfunction

July 20, 2004

Phase II protocol for NX-1207 accepted by FDA

July 19, 2004

Zonagen reports Androxal phase I/II study results

July 19, 2004

Atorvastatin improves erectile function in men with hypercholesterolemia-related ED

July 19, 2004

European marketing authorization for Vesicare for overactive bladder

July 12, 2004

Aminoalcohol derivatives for the treatment of urinary incontinence

July 9, 2004

NexMed and Schering AG sign Alprox-TD agreement

July 8, 2004

BioXell acquires from Roche rights to new indications for BXL-628

July 6, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...